The Pharmaceutical Society of Australia (PSA) today announces the appointment of Ayomide Ogundipe MPS as the National Board’s Early Career Pharmacist Board Director.
Ms Ogundipe was appointed following the conclusion of the former Director Deanna Mill’s term.
Ayomide is a community pharmacist, researcher and academic based in Perth, Western Australia. Since graduating from Curtin University in 2017, Ayomide has developed her practice in a range of areas. She is particularly passionate about digital health transformation, currently researching the technological needs of pharmacists to enable contemporary pharmacy practice in current and emerging roles.
PSA Chief Executive Officer Adj A/Prof Steve Morris welcomed Ms Ogundipe to the Board, and thanked Deanna Mill for her service since 2021.
“We’re proud to elevate ECP voices on the PSA Board, ensuring that we are best supporting pharmacists at all stages of their careers,” Adj A/Prof Morris said.
“Ayomide brings a depth of experience to the PSA Board, in addition to her role as Vice-President of PSA’s Western Australia branch.
“I look forward to working with her to continue Deanna’s work in advocating for and leading PSA’s Early Career Pharmacists.”
“I wish Deanna all the best for what comes next, and sincerely thank her for her outstanding work over the last two years, including chairing the Early Career Pharmacist Community of Specialty Interest.
“Deanna has also played a significant role in the development of reimagined Professional Practice Standards that will be launched at PSA23, including as Chair of the Project Advisory group.
“On behalf of the PSA Board, we thank Deanna for her contributions to our organisation,” Adj A/Prof Morris concluded.
Media contact: Georgia Clarke M: 0480 099 798 E: [email protected]
The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s 36,000 pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system.
